Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9-301-088
Published by: Harvard Business Publishing
Originally published in: 2001
Version: 26 January 2001
Length: 16 pages
Data source: Field research

Abstract

The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation, other pharmaceutical companies, and the government of Botswana.
Locations:
Industry:
Size:
USD32.7 billion sales, 62,000 employees
Other setting(s):
2000

About

Abstract

The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation, other pharmaceutical companies, and the government of Botswana.

Settings

Locations:
Industry:
Size:
USD32.7 billion sales, 62,000 employees
Other setting(s):
2000

Related